Keyword: Racing Medication and Testing Consortium

  • Los Alamitos Race Course

    CHRB Approves Medication-Based Conditions

    The California Horse Racing Board unanimously approved a measure to allow races to be run with medication-based eligibility conditions during its regularly scheduled monthly meeting Feb. 23 at Santa Anita Park.

  • medications prepared and laid out

    Jockey Club Opposes Multiple Violator Changes

    The Jockey Club plans to actively oppose changes to the current multiple medication violation penalty system currently on the agenda for the Association of Racing Commissioners International Model Rules Committee Dec. 8 in Tucson, Ariz.

  • Keeping Pace

    Proposed Multiple Medication Violator Changes

    Looking at proposed changes being considered for the multiple medication violation penalty system (MMV), it's not readily clear how these changes—when you just look at factors like reduced points for some infractions—would play out in the real world.

  • Syringe for use on equine animals on May 24, 2006, in Lexington, Ky.

    Kentucky Likely to Put Labs to the Test

    The Kentucky Horse Racing Commission will likely run double-blind quality assurance testing on its lab after the state’s Equine Drug Research Council approved plans to carry out such tests.

  • A case involving Corvus shed light on how Maryland stewards were handling medication violations.

    Maryland Backs Medication Penalty Model Rule

    The Maryland Racing Commission on Oct. 19 adopted the Association of Racing Commissioners International model rules on medication penalties—rules that most observers thought the commission had adopted back in 2014.

  • Dionne Benson

    RMTC Letter Addresses Motion Overage

    Dionne Benson, executive director of the Racing Medication & Testing Consortium, submitted this letter to BloodHorse on the 2015 methocarbamol positive in Kentucky of trainer Graham Motion which was upheld Oct. 11 by the KHRC.

  • RMTC Committee Accredits New York Laboratory

    The Horseracing Testing Laboratory Committee of the Racing Medication and Testing Consortium (RMTC) met Sept. 9 and voted to fully accredit the New York Drug Testing Laboratory (NYDTL) pursuant to the RMTC laboratory accreditation program.

  • Ed Martin

    Out-of-Competition Proposal Fails to Advance

    A rules committee for horse racing's umbrella group of regulators, the Association of Racing Commissioners, failed to advance an industry-supported recommendation on expanded out-of-competition testing at its meeting July 14 in Seattle.

  • Alan Foreman

    Adoption of Penalty System Considered Key

    Of the four parts of the National Uniform Medication Program, the multiple medication violation penalty system has been adopted by the lowest number of jurisdictions. But one official April 11 said he expects that to change.

  • Alan Foreman

    Foreman Believes in Science Behind Thresholds

    Thoroughbred Horsemen's Association chairman Alan Foreman is confident a 2015 decision not to pursue a medication overage case against trainer Todd Pletcher won't negatively impact the National Uniform Medication Program.

  • Racing Medication and Testing Consortium executive director Dionne Benson

    RCI Looks at Added Out-of-Competition Testing

    Racing Medication and Testing Consortium executive director Dionne Benson said as regulators look at new, enhanced recommendations on out-of-competition testing, they're going to find policies that will work for the industry.

  • RMTC Board Changes Three Drug Thresholds

    The board voted to revise thresholds for three medications on the list of controlled therapeutic substances, and recommended expanding an out-of-competition testing program that would include a list of prohibited substances.

  • RMTC Outlines Procedures on Drug Guidelines

    The Racing Medication and Testing Consortium Feb. 19 issued an overview of its procedures in setting withdrawal times and drug-testing threshold levels after the National HBPA said it would pursue its own research.

  • Hair-Sample Testing Focus of Workshop

    Protocol in the testing of equine hair samples was the focus of a racing chemist's workshop organized by the Racing Medication and Testing Consortium and held at the University of California-Davis.

  • Safety Alliance Standards Updates Approved

    The National Thoroughbred Racing Association announced that an updated set of racetrack safety and integrity standards has been approved by members of the NTRA Safety & Integrity Alliance Advisory Board and the NTRA board.

  • RMTC Defends Methocarbamol Threshold

    A day after prominent trainer Graham Motion questioned the research conducted to determine the threshold level and withdrawal time for methocarbamol (Robaxin), the RMTC defended its efforts.

  • United States Rep. Paul Tonko at the Saratoga Institute on Racing, Equine, and Gaming Law conference.

    Debate Over Federal Bill Begins in Earnest

    A co-sponsor of federal legislation that would authorize oversight of equine medication and drug-testing said Congress could schedule a committee hearing on the bill this fall. Meanwhile, the debate on the bill continues.

  • KEDRC Makes Cobalt Policy Recommendation

    The Kentucky Equine Drug Research Council will advise the Kentucky Horse Racing Commission to adopt policies on the mineral cobalt in line with a Racing Medication and Testing Consortium recommendation.

  • Vets Address Ohio Commission on Medication

    Racetrack veterinarians told the Ohio State Racing Commission April 28 they support uniform medication policies, but because their top priority is the welfare of the racehorse, the state's rules should remain in place.

  • RCI Board Approves Cobalt Regulations

    The Association of Racing Commissioners International board of directors April 23 approved a testing threshold level and penalties for the mineral cobalt, a naturally occurring substance in racehorses.

  • RMTC Committee Approves GABA Threshold

    The executive committee of the Racing Medication and Testing Consortium (RMTC) has approved a uniform testing threshold of 110 parts per billion (ppb) in blood for the naturally occurring amino acid gamma-aminobutyric acid.

  • RMTC Board Announces Cobalt Threshold

    The board of directors of the Racing Medication and Testing Consortium (RMTC) today announced that a uniform threshold for cobalt regulation in the U.S. was approved at its March 24 meeting at Gulfstream Park.

  • Op-Ed: U.S. Must Get Tougher on Cobalt

    Setting the testing threshold for cobalt chloride has become the challenge of racing regulators. North American racing has been well behind in its application of a satisfactory testing threshold applied across all states.

  • Ohio Begins Fact-Finding on Medication Policy

    As the Ohio State Racing Commission begins a comprehensive review of its medication rules and examines the National Uniform Medication Program, it has a hired a longtime veterinarian to consult on policies and procedures.

  • Regulation of Cobalt Slowly Moving Forward

    The Racing Medication and Testing Consortium may be close to recommending policy on the endogenous element cobalt, which when administered in high doses is believed to enhance production of red blood cells.

  • Anabolic Steroids Still Issue in U.S. Racing

    In 2014, U.S. horse racing appeared on pace to register its fewest positive drug tests for anabolic steroids since the industry moved to outlaw the drugs from racing in 2008-09. But recent events in Maryland changed that.

  • Ohio Begins Examination of Medication Rules

    As part of an examination of its equine medication rules, the Ohio State Racing Commission in February will begin hearing from various industry organizations involved in an effort to adopt uniform policies for all states.

  • RMTC Plans Changes but No Merger with RCI

    The industry's Racing Medication and Testing Consortium plans to reorganize its own Scientific Advisory Committee but does not plan to merge with the Association of Racing Commissioners International.

  • New York to Act on New Medication Rules

    New York regulators are ready to consider final revisions to rules specifying allowable testing threshold levels for two dozen medications used to treat Thoroughbreds in advance of races.